CN100444837C - 用于治疗癌的新草本化学组合物 - Google Patents

用于治疗癌的新草本化学组合物 Download PDF

Info

Publication number
CN100444837C
CN100444837C CNB018239242A CN01823924A CN100444837C CN 100444837 C CN100444837 C CN 100444837C CN B018239242 A CNB018239242 A CN B018239242A CN 01823924 A CN01823924 A CN 01823924A CN 100444837 C CN100444837 C CN 100444837C
Authority
CN
China
Prior art keywords
cancer
compositions
purposes
another embodiment
cell line
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018239242A
Other languages
English (en)
Chinese (zh)
Other versions
CN1582160A (zh
Inventor
J·M·拉奥
P·V·斯里尼瓦斯
J·S·亚达夫
K·V·拉加万
A·K·萨克塞纳
M·尚穆加维尔
H·坎帕西
G·N·卡齐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Aria Vidio Zara Co
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aria Vidio Zara Co, Council of Scientific and Industrial Research CSIR filed Critical Aria Vidio Zara Co
Publication of CN1582160A publication Critical patent/CN1582160A/zh
Application granted granted Critical
Publication of CN100444837C publication Critical patent/CN100444837C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB018239242A 2001-12-05 2001-12-05 用于治疗癌的新草本化学组合物 Expired - Fee Related CN100444837C (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2001/000214 WO2003047608A1 (en) 2001-12-05 2001-12-05 A novel herbal chemical composition for the treatment of cancer

Publications (2)

Publication Number Publication Date
CN1582160A CN1582160A (zh) 2005-02-16
CN100444837C true CN100444837C (zh) 2008-12-24

Family

ID=11076415

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018239242A Expired - Fee Related CN100444837C (zh) 2001-12-05 2001-12-05 用于治疗癌的新草本化学组合物

Country Status (7)

Country Link
EP (1) EP1465645A1 (https=)
JP (1) JP2005511659A (https=)
KR (1) KR20040072646A (https=)
CN (1) CN100444837C (https=)
AU (1) AU2002222501A1 (https=)
CA (1) CA2469093A1 (https=)
WO (1) WO2003047608A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20106293A0 (fi) 2010-12-06 2010-12-06 Emilia Peuhu Uudet farmaseuttiset koostumukset
KR101416505B1 (ko) * 2012-03-15 2014-07-09 연세대학교 산학협력단 마타이레시놀을 포함하는 혈관신생 억제용 약제학적 조성물
CN104523721A (zh) * 2014-11-11 2015-04-22 济南星懿医药技术有限公司 一种抗肿瘤的药物组合物
CN109206394B (zh) * 2018-08-16 2022-04-01 广西壮族自治区中国科学院广西植物研究所 一种倍半木脂素化合物、其制备方法及应用
CN113633704B (zh) * 2021-08-23 2022-06-07 中山大学 一种细轴荛花叶提取物的制备方法及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Enantioselective synthesis of (-)-Wikstromol using a newapproach via malic acid. Sefkow, Michael.J. ORG. CHEM.,Vol.66 No.7. 2001 *
Free radical scavenging active components from Cedrus Deodara. Tiwari ashok k et al.JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,Vol.49 No.10. 2001 *
Lignans of Taxus baccata. DAS B ET AL.FITOTERAPIA,Vol.66 No.5. 1995 *
Natural flavonoids and lignans are potent cytostatic agentsagainst human leukemic HL-60 cells. HIRANO TOSHIHIKO ET AL.LIFE SCIENCES,Vol.55 No.13. 1994 *
Wikstromol, Antitumor Lignan from Wikstroemia uva-ursi Gray(Thymelaeaceae). Sterling J. Torrance et al.JOURNAL OF PHARMACEUTICAL SCIENCE,Vol.68 No.5. 1979 *

Also Published As

Publication number Publication date
CN1582160A (zh) 2005-02-16
WO2003047608A1 (en) 2003-06-12
JP2005511659A (ja) 2005-04-28
CA2469093A1 (en) 2003-06-12
EP1465645A1 (en) 2004-10-13
AU2002222501A1 (en) 2003-06-17
KR20040072646A (ko) 2004-08-18

Similar Documents

Publication Publication Date Title
JPS62240619A (ja) 制癌剤
KR102456294B1 (ko) 코로나바이러스 감염 예방 및 치료용 약학 조성물
CN1646112A (zh) 能作为抗白血病药物的草药分子
JPS62501360A (ja) 製薬学的に活性な化合物を含有する病気治療剤
CN100444837C (zh) 用于治疗癌的新草本化学组合物
US6649650B2 (en) Herbal chemical composition for the treatment of cancer
JPS61109713A (ja) 抗腫瘍剤
WO2023076547A1 (en) Deuterated forms of alkaloid compounds and therapeutic uses thereof
JP3507511B2 (ja) アルグラビン（ａｒｇｌａｂｉｎ）およびアルグラビン誘導体の薬学的組成物
JPH02311462A (ja) 制ガン剤ならびに制ガン剤として有用な新規複素環化合物またはそれらの塩
US5244662A (en) Medicinal extract from a mixture of phellodendron and defatted seed of croton, and method for it's manufacture
JP2761876B2 (ja) 新規化合物、その製造方法及びその用途
JP7748558B2 (ja) マグノロール及び／又はホノキオールの芳香環アミノ置換誘導体の抗低酸素／酸素欠乏損傷における使用及び医薬組成物
JPS6330416A (ja) 脳循環代謝改善剤
KR101144715B1 (ko) 정자수 증가용 경구 투여제
TW202017578A (zh) 牛樟芝萃取物、牛樟芝組合物的製備方法及醫藥組合物
US5663197A (en) 2-(1-hydroxyethyl)-5-hydroxynaphtho[2,3-b]furan-4,9-dione and antitumor agents comprising this compound
AU605494B2 (en) The use of 15-deoxyspergualine as a pharmaceutical
JPWO2007105353A1 (ja) 植物由来の悪性腫瘍治療薬
JP2988937B2 (ja) 海洋源由来の新規の抗腫瘍性及び抗ウイルス性組成物
US20250360100A1 (en) Anti-cancer derivatives of ovatodiolide and use thereof
KR100470150B1 (ko) 간섬유화 억제 활성을 갖는 메소-디히드로구아이레트산유도체
KR20130106599A (ko) 헤디치움 코로나리움 유래 랍단 디터페노이드 화합물 및 이의 용도
EP3821949B1 (en) Pharmaceutical composition for use in the treatment of a cancer associated with the activation of galectin-1
JPH0723310B2 (ja) 強肝剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: CONNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH; AP

Free format text: FORMER OWNER: CONNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH

Effective date: 20051230

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20051230

Address after: India New Delhi

Applicant after: Council of Scientific & Industrial Research

Co-applicant after: A Liya Wei Diya Sara Co.

Address before: India New Delhi

Applicant before: Council of Scientific & Industrial Research

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20081224

Termination date: 20141205

EXPY Termination of patent right or utility model